RARA and acute myeloid leukemia: As H3K27ac at enhancers specifically separated APL from AML and as PML-RARA binding sites correlated best with H3K27ac (Fig. 1d, Fig. S4a, Fig. 2a), we next characterized the epigenetic status of APL-specific enhancer states using H3K27ac ChIP-seq data.